Agomab Spain S.L. clinical trials
Acquired by Agomab Therapeutics NV, Dec 14, 2021 · source ↗
The registry lists 3 studies whose lead sponsor is Agomab Spain S.L. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 23, 2026.
- 3studies on the registry
- 0open to participants now
Before and after it joined Agomab Therapeutics NV
- First submitted before Agomab Spain S.L. became part of Agomab Therapeutics NV
- 0
- First submitted after Agomab Spain S.L. became part of Agomab Therapeutics NV
- 3
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Agomab Spain S.L.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 2
All 3 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed3100%
Over the years
- 223
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Agomab Spain S.L.3 studies
Something wrong with this grouping? Tell us on the Agomab Therapeutics NV page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Agomab Therapeutics NV studies →
- Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPFCompletedNCT06181370Phase 1
Sponsor listed in the registry: Agomab Spain S.L. · First submitted after Agomab Spain S.L. became part of Agomab Therapeutics NV
- Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy ParticipantsCompletedNCT05937386Phase 1
Sponsor listed in the registry: Agomab Spain S.L. · First submitted after Agomab Spain S.L. became part of Agomab Therapeutics NV
- Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy ParticipantsCompletedNCT06397508Phase 1
Sponsor listed in the registry: Agomab Spain S.L. · First submitted after Agomab Spain S.L. became part of Agomab Therapeutics NV